Barclays’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-49,003
| Closed | -$6.46M | – | 5661 |
|
|
2025
Q1 | $6.46M | Buy |
49,003
+13,510
| +38% | +$1.68M | ﹤0.01% | 1723 |
|
|
2024
Q4 | $2.96M | Buy |
35,493
+1,040
| +3% | +$85.5K | ﹤0.01% | 2593 |
|
|
2024
Q3 | $2.52M | Buy |
34,453
+25,435
| +282% | +$1.91M | ﹤0.01% | 2663 |
|
|
2024
Q2 | $618K | Sell |
9,018
-83,403
| -90% | -$5.78M | ﹤0.01% | 2911 |
|
|
2024
Q1 | $6.4M | Sell |
92,421
-115,093
| -55% | -$7.91M | ﹤0.01% | 1685 |
|
|
2023
Q4 | $14.9M | Buy |
207,514
+143,826
| +226% | +$8.27M | 0.01% | 1231 |
|
|
2023
Q3 | $3.32M | Buy |
63,688
+21,643
| +51% | +$1.26M | ﹤0.01% | 1578 |
|
|
2023
Q2 | $2.66M | Sell |
42,045
-197,791
| -82% | -$12.3M | ﹤0.01% | 1695 |
|
|
2023
Q1 | $13M | Buy |
239,836
+50,307
| +27% | +$2.43M | 0.01% | 1055 |
|
|
2022
Q4 | $10M | Buy |
189,529
+124,090
| +190% | +$6.22M | 0.01% | 1203 |
|
|
2022
Q3 | $3.04M | Buy |
65,439
+38,286
| +141% | +$2M | ﹤0.01% | 1462 |
|
|
2022
Q2 | $1.55M | Sell |
27,153
-10,679
| -28% | -$605K | ﹤0.01% | 2030 |
|
|
2022
Q1 | $2.31M | Sell |
37,832
-65,138
| -63% | -$3.38M | ﹤0.01% | 1761 |
|
|
2021
Q4 | $5.39M | Buy |
102,970
+57,867
| +128% | +$2.43M | ﹤0.01% | 1652 |
|
|
2021
Q3 | $1.68M | Buy |
45,103
+27,632
| +158% | +$961K | ﹤0.01% | 2465 |
|
|
2021
Q2 | $714K | Sell |
17,471
-76,894
| -81% | -$2.84M | ﹤0.01% | 2877 |
|
|
2021
Q1 | $3.2M | Sell |
94,365
-62,365
| -40% | -$2.16M | ﹤0.01% | 1891 |
|
|
2020
Q4 | $4.98M | Buy |
156,730
+13,614
| +10% | +$358K | 0.01% | 1529 |
|
|
2020
Q3 | $3.67M | Buy |
143,116
+52,394
| +58% | +$1.2M | ﹤0.01% | 1619 |
|
|
2020
Q2 | $2.33M | Buy |
90,722
+68,101
| +301% | +$1.38M | ﹤0.01% | 1979 |
|
|
2020
Q1 | $349K | Sell |
22,621
-48,477
| -68% | -$1.05M | ﹤0.01% | 3868 |
|
|
2019
Q4 | $2.44M | Buy |
71,098
+37,768
| +113% | +$453K | ﹤0.01% | 2790 |
|
|
2019
Q3 | $249K | Sell |
33,330
-6,584
| -16% | -$63.1K | ﹤0.01% | 4811 |
|
|
2019
Q2 | $518K | Buy |
39,914
+14,258
| +56% | +$183K | ﹤0.01% | 4289 |
|
|
2019
Q1 | $313K | Buy |
25,656
+3,705
| +17% | +$47.3K | ﹤0.01% | 4497 |
|
|
2018
Q4 | $250K | Sell |
21,951
-5,450
| -20% | -$88K | ﹤0.01% | 4429 |
|
|
2018
Q3 | $594K | Buy |
27,401
+24,120
| +735% | +$504K | ﹤0.01% | 4121 |
|
|
2018
Q2 | $58K | Sell |
3,281
-7,528
| -70% | -$153K | ﹤0.01% | 5573 |
|
|
2018
Q1 | $228K | Sell |
10,809
-19,758
| -65% | -$385K | ﹤0.01% | 4724 |
|
|
2017
Q4 | $442K | Sell |
30,567
-34,031
| -53% | -$525K | ﹤0.01% | 3981 |
|
|
2017
Q3 | $1.02M | Sell |
64,598
-77,839
| -55% | -$1.14M | ﹤0.01% | 2986 |
|
|
2017
Q2 | $1.77M | Buy |
142,437
+140,155
| +6,142% | +$1.63M | ﹤0.01% | 2365 |
|
|
2017
Q1 | $37K | Sell |
2,282
-571
| -20% | -$8.26K | ﹤0.01% | 5502 |
|
|
2016
Q4 | $43K | Buy |
2,853
+246
| +9% | +$3.47K | ﹤0.01% | 5262 |
|
|
2016
Q3 | $40K | Sell |
2,607
-6,693
| -72% | -$271K | ﹤0.01% | 5110 |
|
|
2016
Q2 | $361K | Buy |
9,300
+9,290
| +92,900% | +$334K | ﹤0.01% | 3479 |
|
|
2016
Q1 | $0 | Buy |
+10
| New | +$333 | ﹤0.01% | 6512 |
|
|
2015
Q4 | – | Sell |
-29,794
| Closed | -$1.19M | – | 6699 |
|
|
2015
Q3 | $1.19M | Buy |
29,794
+29,260
| +5,479% | +$954K | ﹤0.01% | 2549 |
|
|
2015
Q2 | $17K | Sell |
534
-3,017
| -85% | -$76.5K | ﹤0.01% | 5790 |
|
|
2015
Q1 | $82K | Buy |
3,551
+236
| +7% | +$5.29K | ﹤0.01% | 4968 |
|
|
2014
Q4 | $57K | Buy |
3,315
+2,721
| +458% | +$42.5K | ﹤0.01% | 5618 |
|
|
2014
Q3 | $7K | Buy |
594
+186
| +46% | +$2.79K | ﹤0.01% | 7057 |
|
|
2014
Q2 | $7K | Buy |
408
+308
| +308% | +$5.09K | ﹤0.01% | 7010 |
|
|
2014
Q1 | $2K | Buy |
+100
| New | +$1.8K | ﹤0.01% | 7412 |
|
Other funds holding ITCI
KIM
HNB